Evidence Intelligence™
- ImpactScore™
- 100
- Very Positive
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ConsistencyScore™
- unclear
- Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence TrackerResumen de Investigación
Analyzed using Evidence Intelligence™
Women and frailty linked to poorer adherence in diabetes trial
Última actualización 3 de julio de 2026
Key finding
7312 (47.2%) participants were fully adherent to aspirin.
The ASCEND study investigated cardiovascular events in diabetic participants through a randomized controlled trial involving aspirin and omega-3 fatty acid supplementation.
Quick read
Study at a glance
The essential study design details in one scan.
EvidenceScore™
Moderate
Study type
RCTs
Follow-up
Extended (5–20+ y)
Risk of bias
Some Concerns
Guarda investigacion, organiza estudios y vuelve a encontrar evidencia importante rapidamente.
Plain-language summary
What this paper says
A plain-language read of the study's main message and where it applies.
Study focus
The ASCEND study investigated cardiovascular events in diabetic participants through a randomized controlled trial involving aspirin and omega-3 fatty acid supplementation.
Clinical relevance
Understanding adherence rates and predictors is crucial for improving treatment strategies in diabetic patients at risk for cardiovascular events. This study highlights the need for targeted interventions to enhance adherence, which can ultimately lead to better health outcomes.
Keep in mind
Effectiveness of interventions remains unclear. Adherence rates may not reflect long-term outcomes. Generalizability may be limited to specific diabetic populations.
Published in
Referencia de la Revista
Publication details and source links for this paper.
Vichithranie WM, Marion M, Georgina B, Louise B, Jane A. ASCEND: A Study of Cardiovascular Events in Diabetes. Trials. 2026;27:183. doi:10.1186/s13063-026-09551-4
Efectos Principales
7312 participants (47.2%) were fully adherent to aspirin.
8937 participants (57.7%) were fully adherent to omega-3.
Adherence decreased with increasing frailty, smoking, and vascular risk score.
Evidence network
How this study fits
Understand where this research contributes within the broader evidence network.
Evidence Context
This study contributes evidence to Aspirin, Omega-3 Fatty Acid Supplementation and Adherence to aspirin, Treatment adherence, Adherence Predictors for Omega-3, and 1 more.
This study contributes evidence to
Primary intervention
Aspirin
Primary outcomes
- Adherence to aspirin
- Treatment adherence
- Adherence Predictors for Omega-3
Evidence topics
Primary intervention
Evidence relationships
Intervention and outcome relationships this study adds to the evidence network.
4
Evidence pairs
4
Relationships
1
Evidence topics
contributes_evidence
Editorial context
Why this study matters
See why this paper is useful beyond its individual results.
Evidence network role
This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.
Moderate contributionModerate confidenceNetwork score: 63
1
Related topics
4
Evidence pairs
54
Related studies
High relevance in at least one topic
Why it is useful
- Contributes to 4 evidence relationships
- Includes primary outcome data
- Linked to 1 direct semantic evidence topic
Topic contributions
Evidence topic
Contributes evidence
Agrega evidencia relacionada a tu Evidence Tracker
Guarda estudios y paginas de evidencia, organiza tu Evidence Tracker y manten en un solo lugar la investigacion que te importa.
Evidencia principal
Relación de evidencia
Omega-3 Fatty Acid Supplements and Treatment Adherence
Evidencia relacionada
Tema de evidencia
Treatment Adherence
Seguir evidencia
Intervención
Omega-3 Fatty Acid Supplements
Seguir intervención
Core evidence
Study findings
The primary outcomes reported in this study.
Evidence Intelligence™
- ImpactScore™
- 50
- Neutral
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ConsistencyScore™
- unclear
- Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence TrackerAdherence Predictors for Omega-3
Omega-3 Fatty Acid Supplementation → Adherence Predictors for Omega-3
Omega-3 Fatty Acid Supplementation → Adherence Predictors for Omega-3
Evidence Intelligence™
- ImpactScore™
- 50
- Neutral
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ConsistencyScore™
- unclear
- Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence TrackerAdherence to Omega-3
Omega-3 Fatty Acid Supplementation → Adherence to Omega-3
Omega-3 Fatty Acid Supplementation → Adherence to Omega-3
Evidence Intelligence™
- ImpactScore™
- 100
- Very Positive
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ConsistencyScore™
- unclear
- Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence TrackerEvidence Library
Build your evidence library
Save research, organize studies, and quickly find important evidence again.
La Evidencia Sugiere
- 47.2% adherence to aspirin and placebo.
- 57.7% adherence to omega-3 and its placebo.
- Adherence predictors included frailty, smoking, and vascular risk.
A quién se aplica
- Adults with diabetes.
- Individuals at risk for cardiovascular events.
Tener en Cuenta
- The study's effectiveness findings are unclear.
- Adherence rates may vary in different populations.
- Results may not apply to non-diabetic individuals.
Entre Líneas
- Effectiveness of interventions remains unclear.
- Adherence rates may not reflect long-term outcomes.
- Generalizability may be limited to specific diabetic populations.
Evidence Library
Build your evidence library
Save research, organize studies, and quickly find important evidence again.
Connected Evidence
Explore related studies, evidence collections, and research questions.
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
This study contributes to evidence on Aspirin and Treatment Adherence, Aspirin and Treatment Adherence.
Relaciones de evidencia relacionadas
Explore in Evidence ArchiveThis study contributes to the evidence on the following intervention-outcome relationships.
Medications
Detailed evidenceAspirin → Treatment Adherence
Medications
Evidence Intelligence™
- ImpactScore™
- 100
- Very Positive
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ConsistencyScore™
- unclear
- Not enough independent studies
Supporting studies: Based on 1 study
View evidenceMedications
Detailed evidenceAspirin → Treatment Adherence
Medications
Evidence Intelligence™
- ImpactScore™
- 50
- Neutral
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ConsistencyScore™
- unclear
- Not enough independent studies
Supporting studies: Based on 1 study
View evidenceIncluido en estas colecciones de evidencia
Curated evidence collections and hubs this study is part of.
Aspirin Evidence Hub
All studies on Aspirin
1 studies
intervention_hubContributes to Aspirin evidence base.
Treatment Adherence Evidence Hub
All studies measuring Treatment Adherence
1 studies
outcome_hubMeasures Treatment Adherence as a key outcome.
Recent Diabetes Research
Latest published studies
recency_collection
Published within the last 2 years.
Explora más en el archivo de evidencia
Jump to pre-filtered views in the evidence archive.
All studies on Aspirin and Adherence to aspirin
Intervention: AspirinOutcome: Adherence to aspirin
1 results
All studies on Aspirin and Treatment adherence
Intervention: AspirinOutcome: Treatment adherence
1 results
All studies on Aspirin
Intervention: Aspirin
1 results
All studies measuring Adherence to aspirin
Outcome: Adherence to aspirin
1 results
All studies measuring Treatment adherence
Outcome: Treatment adherence
1 results
Questions answered by this study
Generated from the study's connected evidence using Evidence Intelligence™.
Does Omega-3 Fatty Acid Supplements improve treatment adherence?
Emerging Evidence
Current evidence does not show a clear benefit of Omega-3 Fatty Acid Supplements for Treatment Adherence.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
Adherence to Omega-3
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
- 2
Adherence Predictors for Omega-3
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
- Consistency cannot yet be determined.
- Population details are unavailable.
Does Aspirin improve adherence to aspirin?
Emerging Evidence
Aspirin appears to improve Adherence to aspirin.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
Adherence to aspirin
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
- Consistency cannot yet be determined.
- Population details are unavailable.
Does Aspirin improve treatment adherence?
Emerging Evidence
Current evidence does not show a clear benefit of Aspirin for Treatment adherence.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
Treatment adherence
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
- Consistency cannot yet be determined.
- Population details are unavailable.
Next steps
Continue your research
Choose a next path through related evidence topics, archive views, and research summaries.
Explore in archive
Open broader archive views for this relationship.
Related research
Read related research summaries.
Omega-3 improves periodontal health and glycemic control in diabetesLinking Eye Screening Data Improves Understanding of Diabetes TreatmentsResistance training may help reverse prediabetes and improve strengthSmartphone intervention improves medication adherence in diabetes patientsTicagrelor monotherapy reduces bleeding in diabetic ACS patients
No ads. No tracking.
Focused on evidence, not advertising.
Secure & private
Your data is always protected.
Always up to date
New studies added every day.